NCT07090330 - ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 18, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

May 31, 2027

Conditions

Plaque Psoriasis

Interventions

DRUG

ORKA-001 Induction Dose

ORKA-001 Induction Dose, administered by subcutaneous (SC) injection

OTHER

Placebo

Placebo administered by subcutaneous (SC) injection

DRUG

ORKA-001 Maintenance Dose

ORKA-001 Maintenance Dose, administered by subcutaneous (SC) injection

Trial Locations (22)

10023

RECRUITING

Oruka Therapeutics Investigative Site, New York

10029

RECRUITING

Oruka Therapeutics Investigative Site, New York

20850

RECRUITING

Oruka Therapeutics Investigative Site, Rockville

33134

RECRUITING

Oruka Therapeutics Investigative Site, Coral Gables

42104

RECRUITING

Oruka Therapeutics Investigative Site, Bowling Green

48202

RECRUITING

Oruka Therapeutics Investigative Site, Detroit

53226

RECRUITING

Oruka Therapeutics Investigative Site, Milwaukee

90045

RECRUITING

Oruka Therapeutics Investigative Site, Los Angeles

90404

RECRUITING

Oruka Therapeutics Investigative Site, Santa Monica

92123

RECRUITING

Oruka Therapeutics Investigative Site, San Diego

92701

RECRUITING

Oruka Therapeutics Investigative Site, Santa Ana

92708

RECRUITING

Oruka Therapeutics Investigative Site, Fountain Valley

97201

RECRUITING

Oruka Therapeutics Investigative Site, Portland

06416

RECRUITING

Oruka Therapeutics Investigative Site, Cromwell

02111

RECRUITING

Oruka Therapeutics Investigative Site, Boston

V3R 6A7

RECRUITING

Oruka Therapeutics Investigative Site, Surrey

L8N 1Y2

RECRUITING

Oruka Therapeutics Investigative Site, Hamilton

N6H 5LS

RECRUITING

Oruka Therapeutics Investigative Site, London

L3P 1X3

RECRUITING

Oruka Therapeutics Investigative Site, Markham

K9J 5K2

RECRUITING

Oruka Therapeutics Investigative Site, Peterborough

M4W 2N4

RECRUITING

Oruka Therapeutics Investigative Site, Toronto

N2J 1C4

RECRUITING

Oruka Therapeutics Investigative Site, Waterloo